Clin2
NCT07278986Likely a fitRecruiting

Imaging dye during endometrial cancer surgery

Endometrial CancerNear Infrared Fluorescence ImagingCYTALUX (Pafolacianine) InjectionPlanned Diagnostic Laparoscopies

Treatments studied

Part of Cancer, Women’s health & pregnancy clinical trials.

This trial tests a dye (CYTALUX) that helps surgeons see endometrial cancer during surgery. You may be eligible if you have endometrial cancer and are scheduled for surgery.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
10 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with endometrial cancer.
  • You are scheduled to have surgery for your cancer.
  • You agree to stop taking folic acid supplements at least 48 hours before the dye is given.
  • You are not pregnant or plan to become pregnant during the study.
  • You have no history of allergic reactions to the dye or similar products.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06656949Recruiting
ICG injection for lymph node mapping in endometrial cancer

This trial tests whether injecting a dye called indocyanine green (ICG) in different spots can better find sentinel lymph nodes during surgery for endometrial cancer. It may help doctors remove fewer nodes and reduce side effects.

Jinan, Shandong
NCT07772895Recruiting· Phase 1
Glowing dye to help surgeons see lung cancer during surgery

This trial tests a dye that makes lung cancer cells glow during surgery, helping surgeons remove more of the tumor. It's for people who are already scheduled for lung cancer surgery.

Philadelphia, Pennsylvania
NCT07276789Recruiting· Phase 2
Single-dose dye imaging for lung cancer surgery

This trial tests a single dose of a special dye (LS301-IT) that helps surgeons see lung cancer cells more clearly during surgery. It aims to make lung cancer removal more precise and complete.

Philadelphia, Pennsylvania
NCT07039526Recruiting· Phase 2
Cytalux for finding cancer during surgery

This trial tests a dye called Cytalux that helps surgeons see cancer during surgery. You get the dye before surgery, and it makes cancer cells glow under a special light. This could help doctors remove more cancer.

Dallas, Texas
NCT07124351Recruiting· Phase 4
Using a special dye to see cancer during surgery

This trial tests a drug called pafolacianine (CYTALUX) that makes cancer cells glow during surgery. It may help doctors see and remove more cancer from the stomach, esophagus, or appendix. You take the drug before surgery, and a special camera shows the glowing cancer.

Los Angeles, California
NCT07469202Not yet recruiting· Phase 4
Cytalux dose study for lung or ovarian cancer patients having surgery

This trial tests a dye called Cytalux (pafolacianine) to help surgeons see cancer during lung or ovarian cancer surgery. If you are scheduled for surgery to remove lung cancer or to debulk ovarian cancer, you may be eligible.

Hear when a new Endometrial Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.